1. Introduction {#s0005}
===============

Galanin is a 29--30 amino acid neuropeptide that is dramatically induced after peripheral or central nervous system injury, and plays physiological roles in nociception, memory and cognition, anxiety-related behaviours, feeding, reproduction, neurite outgrowth and as a neuronal trophic factor ([@bb0120; @bb0290; @bb0530; @bb0555]). The N-terminal 15 residues of galanin are strictly conserved between species and the N-terminal end is essential for biological activity ([@bb0290; @bb0555]), binding to the three galanin receptor subtypes Gal~1~, Gal~2~ and Gal~3~ (*GalR1*--*3* gene products), which are each Class A rhodopsin-like G protein-coupled receptors (GPCRs) that differ in sites of expression, functional coupling and signalling activities ([@bb0555]). The phenotypes of mice deficient in each of the galanin receptors have recently been reviewed ([@bb0060; @bb0290; @bb0555]). Gal~1--3~ are also bound by galanin-like peptide (GALP), but not by the GALP alternatively spliced product alarin ([@bb0555]), and recently the neuropeptide spexin/NPQ (neuropeptide Q) was also reported to bind to Gal~2~ and Gal~3~ , but not to Gal~1~ ([@bb0270]).

In adult rat the expression of Gal~1~ mRNA is largely restricted to brain, spinal cord and dorsal root ganglia (DRG), whereas Gal~2~ mRNA is also detected in several peripheral tissues such as large intestine and uterus. In contrast, Gal~3~ mRNA has a more restricted distribution within brain, is rare in spinal cord and rare or not present in DRG, and expression in peripheral tissues is controversial ([@bb0070; @bb0225; @bb0390; @bb0470; @bb0550; @bb0555]). By in situ hybridization (ISH), Gal~1~ mRNA is more highly expressed than Gal~2~ overall in brain ([@bb0070]) and by far the highest levels of Gal~2~ detected in the nervous system are in the DRG ([@bb0390]).

In adult mouse brain the distribution of Gal~1~ mRNA by ISH is largely similar to rat ([@bb0210]), whereas the absence of specific \[^125^I\]-galanin binding sites in any region of adult Gal~1~-deficient brain ([@bb0250]) suggests a species-specific, greatly reduced expression of Gal~2~ mRNA. However, it is still detectable by the more sensitive RT-PCR method in both mouse whole brain ([@bb0200; @bb0245]) and subregions including the amygdala, hippocampus and hypothalamus ([@bb0060; @bb0190; @bb0195; @bb0470; @bb0620]), as well as in spinal cord ([@bb0245]), DRG, trigeminal and nodose sensory ganglia ([@bb0200; @bb0395]) and several peripheral tissues ([@bb0035; @bb0200; @bb0245; @bb0265; @bb0400]). Less work has been reported on Gal~3~ mRNA expression, but by RT-PCR it is detected in mouse whole brain and some subregions ([@bb0060; @bb0190; @bb0620]), nodose ganglion ([@bb0395]) and several peripheral tissues ([@bb0035; @bb0060; @bb0265]), but is at the limits of detection in both spinal cord and DRG ([@bb0200; @bb0245]).

Current antibodies against Gal~1~ or Gal~2~ are non-selective under standard immunodetection conditions, with identical immunoreactivity patterns in wild-type and receptor knockout mice ([@bb0185; @bb0290; @bb0320]; F.E.H., P.V. and D.W., unpublished). To delineate the expression of Gal~1~ and Gal~2~ at the protein level we wished to tag each receptor with fluorochromes. The C-terminal tagging of GPCRs with green fluorescent protein (GFP) is generally thought to have no significant effect on GPCR properties e.g. ligand binding, signal transduction and intracellular trafficking ([@bb0080]), and both Gal~1~ and Gal~2~ have been shown to be functional when C-terminally tagged with enhanced GFP (EGFP) or its variants and expressed in cell lines ([@bb0560; @bb0570; @bb0565]). The GPCR superfamily is the largest group of cell surface receptors and are the targets of around one third of marketed drugs, yet to date the only knock-in mice that express a fluorescently-tagged GPCR are Rhodopsin-EGFP and two rhodopsin mutant variants, δ-opioid receptor (DOR)-EGFP and the recently reported μ-opioid receptor (MOR)-mCherry ([@bb0080; @bb0145; @bb0455]). Transgenic mice have been successfully generated expressing either humanized *Renilla* GFP (hrGFP; Stratagene-Agilent; [@bb0595]) under the control of various endogenous promoters ([@bb0445; @bb0415; @bb0535]), or with widespread expression of the monomeric red fluorescent protein mCherry under the control of a ubiquitin-C promoter ([@bb0155; @bb0465]). Here we describe the generation and initial characterization of Gal~1~-mCherry and Gal~2~-hrGFP knock-in mice, focussing on expression in DRG, spinal cord and brain.

2. Materials and methods {#s0010}
========================

2.1. DNA sequence analysis {#s0015}
--------------------------

Planning for knock-in gene characterizations used mouse reference genome Build 37.1, vector hrGFP-FRT*neo*FRT (see below, [Section 2.2](#s0020){ref-type="sec"}) and mCherry cDNA (AY678264) sequences. The RepeatMasker 3.2.9 programme (Smit, Hubley and Green, 1996--2010, <http://www.repeatmasker.org>) was used to select regions of the *GalR1* or *GalR2* genes for retrieval target sites or Southern probes that avoided repetitive DNA elements, and homology arm targets that minimized the presence of repetitive DNA elements. Ribosome profiling data ([@bb0240]) was accessed using the GWIPS-viz. browser (<http://gwips.ucc.ie>; [@bb0355]). The ribosome density peaks for the uORF6 and *GalR2* initiation codons were at, respectively, Chr11 nucleotides (nt) 116,281,254--286 and 116,281,474--509 of the GRCm38/mm10 genome assembly (GWIPS-viz. ribo-seq coverage plot; [@bb0240; @bb0355]).

2.2. Generation of GalR1-mCherry-\[neo^+^\] and GalR2-hrGFP-\[neo^+^\] knock-in mice {#s0020}
------------------------------------------------------------------------------------

Mouse genomic clones including either *GalR1* or *GalR2* genes from the bMQ mouse strain 129S7 (129Sv) bacterial artificial chromosome (BAC) library (inserts 89--178 kb; Source BioScience; [@bb0005]) were electroporated into strain EL250 *Escherichia coli* ([@bb0300]). This allowed temperature-inducible, lambda Red-mediated, homologous recombination into the BAC ([@bb0115; @bb0300]) of PCR products from either vector hrGFP-FRT*neo*FRT ([@bb0020; @bb0405]; hrGFP derived from Stratagene-Agilent vector phrGFP-1, [@bb0595]; [Fig. 2](#f0010){ref-type="fig"}A, *middle panel*) flanked by *GalR2* homologous sequence or vector mCherry-FRT*neo*FRT (hrGFP exchanged for mCherry; [@bb0465]) flanked by *GalR1* homologous sequence. Within the latter PCR product an AseI restriction site was introduced immediately downstream of the 3′ FRT site ([Fig. 1](#f0005){ref-type="fig"}A, *middle panel*), for use in Southern blot digests, and the mCherry/hrGFP heterologous 3′-untranslated region (UTR) has identity to nt 705--1193 of vector pCMV-Script (AF028239) which includes the SV40 early region poly(A) site ([@bb0105]; J02400, nt 2828--2547). Correct insertion into the BAC was validated by DNA sequencing of cloned PCR products of each junction. All DNA sequencing was by Source BioScience, Oxford.

Retrieval from the recombined BAC clones by gap repair ([@bb0115; @bb0300]) into PCR-amplified vector pCR-Blunt (Invitrogen) was mediated by either *GalR1* target sequences with adjacent introduced rare SwaI restriction sites, or *GalR2* target sequences with adjacent introduced BstZ17I restriction sites. Recombined plasmid DNAs were transformed into STBL3 *E. coli* (Invitrogen) and the final targeting constructs were excised with either SwaI (*GalR1*-mCherry-FRT*neo*FRT; 11.3 kb, with *GalR1* homology arms of 4.2 and 3.9 kb) or BstZ17I (*GalR2*-hrGFP-FRT*neo*FRT; 8.1 kb, with *GalR2* homology arms of 2.3 and 2.7 kb).

Targeting construct inserts were electroporated into embryonic stem (ES) cell line E14.1a (strain 129P2/OlaHsd; [@bb0130; @bb0220]) and the SV40-*neo* cassette selected with 250 μg/ml G418 by Geneta (Dept. of Biochemistry, University of Leicester). G418-resistant ES cell clones were screened for correct targeting by PCR (data not shown) and real-time quantitative genomic PCR, and expanded clones were screened by Southern blot analysis (Supplementary Materials and Methods). Selected clones were karyotyped to confirm euploidy, and three ES cell clones of each knock-in gene were injected into 3.5 day old blastocysts from C57BL/6J mice to produce chimeric mice (Geneta). These were crossed to strain 129P2/OlaHsd mice and germline transmission was assessed by PCR genotyping (see below).

2.3. Animals {#s0025}
------------

Mice were housed in a temperature- and humidity-controlled colony on a 14:10 h light--dark cycle, and fed standard chow and water ad libitum. Procedures were carried out in accordance with the U.K. Animals (Scientific Procedures) Act, 1986 and associated guidelines. Ear-punch biopsies were used for PCR genotyping, animals were killed by cervical dislocation to obtain DRG for RT-PCR analysis ([Section 2.6](#s0040){ref-type="sec"}), or primary DRG cultures ([Section 2.7](#s0045){ref-type="sec"}). Three mice had peripheral transection of the right sciatic nerve prior to perfusion seven days later to obtain ipsilateral (axotomized) lumbar L4 and L5 DRG ([@bb0215]) for immunohistochemistry ([Section 2.9](#s0055){ref-type="sec"}).

2.4. PCR genotyping to distinguish knock-in from endogenous receptor alleles {#s0030}
----------------------------------------------------------------------------

Mouse PCR genotyping for *GalR1* used the three primers 5′-AGCCTTCCCACTGACGCCAGCTT-3′, 5′-CAGAACTTACTTTACACCATGGAGATC-3′ and 5′-TCGAACTCGTGGCCGTTCACGGA-3′, which amplified an endogenous *GalR1* product of 547 bp and a *GalR1*-mCherry knock-in product of 348 bp. PCR genotyping for *GalR2* used primers 5′-CGAGGAGAGCTTCAGGCCGAGT-3′, 5′-CACCCTGTAAAGTCCCAGAGACGT-3′ and 5′-CTGGTTGCCGAACAGGATGTTGC-3′, which amplified an endogenous *GalR2* product of 543 bp and a *GalR2*-hrGFP knock-in product of 308 bp. PCRs with FastStart Taq DNA polymerase (Roche) and HPLC-purified primers (MWG Eurofins) used cycling conditions of 94 °C for 7 min, 40 cycles of \[94 °C, 30 s; 63 °C, 45 s; 72 °C, 45 s\], and a final 72 °C incubation for 10 min.

2.5. Deletion of the FRT-flanked SV40-neo cassette from knock-in mice {#s0035}
---------------------------------------------------------------------

Homozygous strain C57BL/6J *ACTB*:*FLPe* transgenic mice ([@bb0065; @bb0440]) from the Bristol University colony (provided by Dr. Alastair Poole and N.B.) were PCR genotyped using primers 5′-CAATACCTGATCACTACTTCGCACT-3′ and 5′-CATGTCTGATCCTCGAGGAGCTC-3′ under standard cycling conditions ([Section 2.4](#s0030){ref-type="sec"}), which amplified the expected 362 bp sequenced product.

Heterozygous *GalR1*-mCherry-\[*neo*^+^\] knock-in mice were crossed to *ACTB*:*FLPe* transgenic mice, and offspring both heterozygous for *GalR1*-mCherry and genetically mosaic for deletion of the SV40-*neo* cassette (Δ*neo*) by PCR genotyping (i.e. both Δ*neo* and *neo*^+^) were then crossed to strain 129P2/OlaHsd. Offspring were PCR genotyped in separate reactions for *GalR1*-mCherry heterozygosity ([Section 2.4](#s0030){ref-type="sec"}), presence of *neo* and presence of Δ*neo*. Primers for presence of *neo* were 5′-GCATACGCTTGATCCGGCTACCT-3′ and 5′-CTCCTTCCGTGTTTCAGTTAGCCT-3 (630 bp product), and for presence of Δ*neo* were 5′-GTCTGTTCATGATCATAATCAGCCAT-3′ (UTR-F; heterologous 3′-UTR sequence) and 5′-CAGAACTTACTTTACACCATGGAGATC-3′ (GalR1R) which amplified the expected 626 bp sequenced product. A similar breeding strategy was used with the heterozygous *GalR2*-hrGFP-\[*neo*^+^\] knock-in mice, except that primers for presence of Δ*neo* were UTR-F and 5′-CCTCAAACTTGATGGCTGGCTTTG-3′ (GalR2R) which with annealing at 65 °C amplified the expected 528 bp sequenced product.

Frozen sperm from homozygous *GalR1*-mCherry (line 33) or *GalR2*-hrGFP (line 32) knock-in mice were deposited at the MRC Frozen Embryo and Sperm Archive and are available from <https://www.infrafrontier.eu>/(GalR1-mCherry, EMMA stock ID EM:08192; GalR2-hrGFP, EMMA stock ID EM:08193).

2.6. Real-time quantitative RT-PCR {#s0040}
----------------------------------

Lumbar DRG from individual, age-matched 7--8 week old wild-type, *GalR1*-mCherry or *GalR2*-hrGFP mice (each *n* = 5; 1 male, 4 females) were frozen on dry ice and stored at − 80 °C, prior to total RNA isolation and reactions containing reverse transcriptase (RT +) or without enzyme (RT − control) ([@bb0260]). Real-time quantitative RT-PCR (reverse transcription polymerase chain reaction) assays and primer and probe sets (Applied Biosystems) for Gal~1~, Gal~2~, galanin and endogenous control glyceraldehyde 3-phosphate dehydrogenase (Gapdh) were as reported ([@bb0200]), except for the corrected Gal~2~ probe sequence 5′-TTCCTCACTATGCACGCCAGCAGC-3′ (mGalR2-46TAQ) used then and herein. Relative mRNA expression levels were derived by the comparative threshold cycle (C~t~) method (2^− ΔΔCT^) normalized to Gapdh ([@bb0200]), with results presented as mean of log transformed data plus SEM. Sample identities were confirmed by standard RT-PCR for Gal~1~-mCherry and Gal~2~-hrGFP receptor-fluorescent tag products (data not shown).

2.7. DRG culture and live-cell imaging {#s0045}
--------------------------------------

DRG cultures from 8 week old mice ([@bb0205]) were generated from individual animals, and neurons were replated onto glass-bottom microwell dishes (MatTek) treated with 0.5 mg/ml polyornithine and 5 μg/ml laminin (Sigma). Immediately prior to imaging, medium was changed to air-buffered L15 (Sigma) supplemented with 5% horse serum, 1 mM [l]{.smallcaps}-glutamine and 10 ng/ml gentamicin. Cell images were recorded using a Leica TCS SP8 confocal system with enhanced sensitivity due to the GaAsP Hybrid detector (HyD), attached to a Leica DMI6000 inverted epifluorescence microscope with a 63 ×/1.30 Glycerol objective lens (Leica Microsystems), at 37 °C. Imaging parameters were selected to optimize confocal resolution. Specifically, GalR1-mCherry was detected by excitation with a HeNe 594 nm laser ([@bb0010]; 80% acousto-optic tunable filter, AOTF) and emission detected at 600--660 nm with 330% gain, 6 × line accumulation, and 2 × frame averaging. GalR2-hrGFP was detected by excitation with a 488 nm argon laser (35% power, with 70% AOTF) and emission detected at 492--538 nm with 400% gain, 6 × line accumulation, and 2 × frame averaging. Confocal images were detected as *z* stacks of *x*--*y* images taken at 1 μm intervals, and were acquired using LCS (Leica) software. Images designated 'adjusted' used linear brightness/contrast functions of Adobe Photoshop software.

2.8. Receptor internalization studies and quantification of somatic cell membrane associated fluorescence {#s0050}
---------------------------------------------------------------------------------------------------------

Immediately prior to imaging the medium was changed to FluoroBrite DMEM (Life Technologies) to decrease background fluorescence, with medium supplements B-27 (Life Technologies), 1 mM [l]{.smallcaps}-glutamine and 10 ng/ml gentamicin. Imaging was at 37 °C with 5% CO~2~ enrichment. Single focal planes were imaged to reduce potential photo-bleaching, with 6 × line accumulation and without frame averaging. Porcine galanin (1--29) was from Bachem. Quantification of somatic cell membrane fluorescence ([@bb0455]) of GalR1-mCherry from original confocal images used Volocity software (Perkin Elmer) to define both the area within the cell membrane (intracellular fluorescence) and between this and the outside of the somatic cell membrane (surface fluorescence). Results are presented as mean plus SEM.

2.9. Immunohistochemical staining {#s0055}
---------------------------------

Mice were deeply anaesthetised and transcardially perfused with PBS followed by 4% paraformaldehyde/PBS. Brains, lumbar spinal cords and lumbar L4 and L5 DRGs were dissected and post-fixed for 24 h in 4% paraformaldehyde/PBS then transferred to 20% sucrose/PBS for 24 h at 4 °C. Spinal cords and DRG were placed in OCT embedding matrix (CellPath) and frozen on dry ice, and brains were frozen on dry ice. Tissue was stored at − 80 °C until use. 10 μm sections of DRG and 30 μm sections of spinal cord and brain were cut on a cryostat. DRG were collected directly onto Polysine slides (Thermo Scientific), or after immunohistochemical processing of floating sections for brain and cord. mCherry was detected using the TSA™ (tyramide signal amplification) Plus Fluorescein System (PerkinElmer). Sections were processed at room temperature as follows: incubated in 0.3% H~2~O~2~/PBS for 30 min to quench endogenous peroxidase; washed 1 × 5 min with TN (0.1 M Tris--HCl, pH 7.5; 0.15 M NaCl); blocked for 30 min in TNB (0.5% Blocking Reagent in TN); and incubated for 18 h in rabbit anti-DsRed antibody (*Discosoma* red fluorescent protein; [@bb0145; @bb0535]; Clontech cat. no. 632,496) diluted 1:500 in TNB. Sections were washed 3 × 5 min in TN; incubated in HRP anti-rabbit IgG (Vector Laboratories cat. no. PI-1000) diluted 1:200 in TNB for 1 h; washed 3 × 5 min in TN; incubated in fluorescein-conjugated tyramide (TSA™ Plus Fluorescein System; PerkinElmer) at 1:50 for 10 min. Sections were washed 3 × 10 min in TN, floating sections collected onto slides, then all sections mounted in Vectashield (Vector Laboratories) and coverslipped. Immunohistochemistry of wild-type tissue verified the specificity of the primary antibody, and omission of the primary antibody verified the absence of non-specific staining by the secondary antibody.

The polyclonal anti-hrGFP antibody ([@bb0445; @bb0600]; Stratagene-Agilent 240,142) was used as above diluted at 1:500 or 1:5000 on DRG (± axotomy) and brain, and at 1:500--1:30,000 on spinal cord (± axotomy), each with wild-type control tissue.

Gal~1~-mCherry immunofluorescence was detected by excitation with a 488 nm argon laser and emission detected at 492--538 nm on a Leica TCS SP5-II confocal system attached to a Leica DMI6000 inverted epifluorescence microscope with dry 20 × or oil 40 × objective lens. Confocal images were detected as *z* stacks of *x*--*y* images taken at 1 μm (DRG/brain) or 2 μm (cord, unless stated in [Fig. 6](#f0030){ref-type="fig"}N and O) intervals with 4 × line accumulation, and selected images extracted using Volocity software (Perkin Elmer). Photomicrographs of Gal~1~-mCherry immunofluorescence in brain at lower magnifications (2.5 ×, 5 ×) used IM50 Image Manager software (Leica; [@bb0215]) with gain set at 1 ([Fig. 7](#f0035){ref-type="fig"}), as constrained by high immunoreactivity in thalamic nuclei, and regions with lesser immunoreactivity used gain set at 2 ([Supplementary Fig. 6](#f0070){ref-type="fig"}). Images were adjusted using linear brightness/contrast functions of Adobe Photoshop software. Identification of mouse lumbar spinal cord laminae followed [@bb0585] and brain regions followed [@bb0160].

Quantification of Gal~1~-mCherry-immunoreactive neuron profiles in 16 μm sections of lumbar L4 and L5 DRG from control unaxotomized animals (*n* = 3) and axotomized animals seven days after axotomy (*n* = 3, ipsilateral; [Section 2.3](#s0025){ref-type="sec"}) was as reported, with counting of 6--10 sections and at least 800 profiles per DRG ([@bb0215]).

2.10. Statistical analysis {#s0060}
--------------------------

Statistical significance of real-time quantitative RT-PCR results ([Section 2.6](#s0040){ref-type="sec"}) and changes in somatic cell membrane fluorescence after galanin addition ([Section 2.8](#s0050){ref-type="sec"}) were judged by two-tailed Student\'s *t*-test, with *P* values \< 0.05 considered significant. *P* values of \< 0.05 and \< 0.01 are indicated by one and two asterisks, respectively.

2.11. Nomenclature {#s0065}
------------------

With respect to nomenclature, the genes *GalR1* and *GalR2* (official symbols, Mouse Genome Informatics Database) encode the gene products Gal~1~ and Gal~2~ (<http://www.guidetopharmacology.org/GRAC/FamilyDisplayForward?familyId=27>), and for convenience transcripts are designated here as Gal~1~ and Gal~2~ mRNAs.

3. Results {#s0070}
==========

3.1. Generation of GalR1-mCherry and GalR2-hrGFP knock-in mouse lines {#s0075}
---------------------------------------------------------------------

The coding sequences of the fluorescent tags mCherry or hrGFP were cloned in-frame onto the 3′ ends of genomic *GalR1* or *GalR2* coding sequences by lambda Red-mediated recombineering, and a smaller subcloned fragment of each was electroporated into embryonic stem (ES) cells (see [Materials and methods](#s0010){ref-type="sec"} section; [Figs. 1](#f0005){ref-type="fig"}A and [2](#f0010){ref-type="fig"}A, *middle panels*). Screening of ES cell clones by real-time quantitative genomic PCR resulted in 6/97 *GalR1*-mCherry clones and 10/40 *GalR2*-hrGFP clones with one correctly targeted, knock-in allele and one endogenous allele of the receptor gene. Correct targeting of selected ES cell clones was confirmed further by Southern blot analysis using 5′ and 3′ probes external to the targeting construct sequence, and internal *neo* probe ([Supplementary Figs. 1 and 2](#f0045 f0050){ref-type="fig"}). Three heterozygous knock-in ES cell clones of *GalR1*-mCherry or *GalR2*-hrGFP were injected into blastocysts to generate chimeras, from which germline transmission of the knock-in allele was confirmed by PCR genotyping for all three *GalR1*-mCherry lines (33, 63 and 97) and one *GalR2*-hrGFP line (32). Expression of knock-in receptor and *neo* mRNAs in adult DRG was demonstrated by RT-PCR ([Supplementary Figs. 3 and 4](#f0055 f0060){ref-type="fig"}).

Gene expression can be perturbed by the presence of a nearby *neo* gene under the control of a strong promoter ([@bb0140; @bb0330; @bb0430]), so the downstream SV40-*neo* cassette selection marker flanked by FRT (FLP recombination target) sites ([Figs. 1](#f0005){ref-type="fig"}A and [2](#f0010){ref-type="fig"}A, *middle panels*) was excised in vivo by crossing with *ACTB*:*FLPe* transgenic mice in which FLPe recombinase is under the direction of the human β-actin promoter ([@bb0065; @bb0440]). Animals heterozygous for *GalR1*-mCherry, negative for *neo*, and positive for deletion of the SV40-*neo* cassette (Δ*neo*) by PCR genotyping were inbred to produce homozygous *GalR1*-mCherry-\[Δ*neo*\] knock-in mice (lines 33 and 97), and the corresponding strategy was used to produce homozygous *GalR2*-hrGFP-\[Δ*neo*\] knock-in mice (see [Materials and methods](#s0010){ref-type="sec"} section). DNA sequencing of Δ*neo* PCR genotyping products confirmed that FLPe had precisely excised the SV40-*neo* cassette resulting in a product with a single remaining recombined FRT site ([Figs. 1](#f0005){ref-type="fig"}A and [2](#f0010){ref-type="fig"}A, *bottom panels*), while Southern blot analysis confirmed both the expected different restriction fragment sizes of knock-in compared to endogenous alleles and the absence of *neo*-hybridizing sequences in *GalR1*-mCherry lines 33 ([Fig. 1](#f0005){ref-type="fig"}B) and 97 (data not shown), and in the *GalR2*-hrGFP knock-in ([Fig. 2](#f0010){ref-type="fig"}B).

3.2. mRNA expression in DRG from knock-in mice {#s0080}
----------------------------------------------

Expression and correct splicing of transcripts from the knock-in genes was assessed by RT-PCR of adult DRG, the *GalR1* and *GalR2* genes having respectively three and two exons ([@bb0400; @bb0545]). *GalR1*-mCherry line 33 expressed the expected spliced product of *GalR1* exons 1--3 fused to mCherry coding sequence (637 bp), mCherry to the heterologous 3′-UTR (431 bp), and did not express *neo* ([Supplementary Fig. 3](#f0055){ref-type="fig"}). Similar results were obtained for *GalR1*-mCherry line 97 (data not shown) which was therefore discontinued. The *GalR2*-hrGFP knock-in expressed the spliced product of coding sequences from *GalR2* exons 1--2 (426 bp), both *GalR2* fused to hrGFP (533 bp) and hrGFP to the heterologous 3′-UTR (483 bp), and did not express *neo* ([Supplementary Fig. 4](#f0060){ref-type="fig"}). The identities of knock-in RT-PCR products were confirmed by DNA sequencing, and it is important to note that products that did not span exons were shown to be RT-dependent i.e. derived from mRNA and not genomic DNA contamination ([Supplementary Figs. 3 and 4](#f0055 f0060){ref-type="fig"}).

Quantitative RT-PCR was used to determine whether expression levels of the knock-in mRNA either differed from wild-type mouse endogenous receptor or led to adaptive regulation of galanin and galanin receptor mRNAs ([@bb0190; @bb0210]). Expression levels in DRG from five individual wild-type, *GalR1*-mCherry knock-in or *GalR2*-hrGFP knock-in mice were compared using previously published assays for Gal~1~, Gal~2~ and galanin spliced coding sequences ([@bb0200]) that are common to both the wild-type and knock-in animals. We have reported previously that Gal~3~ mRNA expression in mouse DRG is too low for reliable comparisons ([@bb0200]). Compared to wild-type mice, there were no significant differences in the levels of Gal~1~ or galanin mRNAs detected in either *GalR1*-mCherry knock-in (0.856 ± 0.177, *P* = 0.165 and 0.904 ± 0.072, *P* = 0.477, respectively) or *GalR2*-hrGFP knock-in mice (1.261 ± 0.099, *P* = 0.067 and 1.102 ± 0.195, *P* = 0.850, respectively). In contrast, levels of Gal~2~ mRNA varied depending on genotype, with a small but significant increase in *GalR1*-mCherry knock-ins (1.361 ± 0.076, *P* = 0.020; \**P* \< 0.05) and a significant decrease in *GalR2*-hrGFP knock-ins (0.524 ± 0.080, *P* = 0.004; \*\**P* \< 0.01).

The quantitative RT-PCR results were also used to compare the relative abundance of different transcripts ([@bb0335; @bb0420]). In wild-type DRG Gal~1~ and Gal~2~ mRNAs were amplified to detectable levels (mean threshold cycle, C~t~) at respectively 25.37 and 32.58 cycles (each *n* = 5), the difference of 7.21 cycles corresponding to Gal~2~ being 148-fold less highly expressed than Gal~1~. These comparatively low expression levels of Gal~2~ mRNA were RT-dependent, i.e. derived from mRNA, as no products were detected in RT-minus controls at 50 cycles.

3.3. Live-cell imaging of Gal~1~-mCherry and Gal~2~-hrGFP proteins in primary DRG neurons from knock-in mice {#s0085}
------------------------------------------------------------------------------------------------------------

In preliminary experiments to detect mCherry or hrGFP fluorescence by confocal microscopy, the PC12 cell line was transiently transfected with either human (h) Gal~1~-mCherry or hGal~2~-hrGFP cDNAs under the control of the strong CMV (cytomegalovirus) promoter/enhancer (data not shown). Imaging conditions were then established for detecting the much lower fluorescence of each knock-in gene product under the control of the endogenous promoter in primary DRG neurons ([Materials and methods](#s0010){ref-type="sec"} section). Cells were detected that expressed a wide range of different levels of Gal~1~-mCherry fluorescence associated with the somatic cell membrane ([Fig. 3](#f0015){ref-type="fig"}A, *middle row*). However, under these sensitive detection conditions the globular, *intracellular* autofluorescence from lipofuscin (see [Discussion](#s0100){ref-type="sec"} section; [@bb0510]) was also readily apparent within the cell bodies of both knock-in and wild-type neurons, which made it impossible to distinguish between specific Gal~1~-mCherry fluorescence and non-specific lipofuscin autofluorescence *within* the neuronal cell bodies ([@bb0460]). Growth cones were also examined, as lipofuscin is limited to the neuronal cell body ([@bb0170]), but Gal~1~-mCherry fluorescence was not detected.

Gal~2~-hrGFP fluorescence was expected to be more difficult to detect than Gal~1~-mCherry, due to the much lower mRNA expression (see above, [Section 3.2](#s0080){ref-type="sec"}). Gal~2~-hrGFP fluorescence at the somatic cell membrane was near the limits of detection, but was detectable in 3 of 150 DRG neurons analysed ([Fig. 3](#f0015){ref-type="fig"}B).

A previous study in transfected CHO cells demonstrated a decrease in fluorescently-tagged Gal~1~ receptor at the cell membrane following incubation with 100 nM--2 μM galanin ([@bb0560]). To study the effect of galanin on Gal~1~-mCherry localization in primary DRG neurons, cells with comparatively high somatic cell membrane fluorescence were selected and imaged at 37 °C in a recently available medium with reduced background fluorescence ([Materials and methods](#s0010){ref-type="sec"} section). In control Gal~1~-mCherry neurons there was no significant decrease in somatic cell membrane fluorescence on re-imaging at 20 min, i.e. no apparent photo-bleaching, whereas the somatic cell membrane fluorescence significantly decreased by 35% in neurons re-imaged 20 min after the addition of 1 μM galanin (65.17 ± 5.18%; *P* = 0.0067; [Fig. 4](#f0020){ref-type="fig"}), demonstrating agonist-induced internalization.

3.4. Immunohistochemical detection of Gal~1~-mCherry protein in DRG, spinal cord and brain of adult knock-in mice {#s0090}
-----------------------------------------------------------------------------------------------------------------

In order to detect Gal~1~-mCherry protein expression with higher sensitivity, we used a previously characterized antibody to mCherry ([@bb0145; @bb0535]) that specifically detected the protein expressed from CMV-driven hGal~1~-mCherry cDNA in transiently transfected PC12 cells (data not shown). Gal~1~-mCherry immunofluorescence in adult lumbar DRG was detected as comparatively high expression in a restricted subset of neurons ([Fig. 5](#f0025){ref-type="fig"}A--C, I), with localization to the somatic cell membrane and a punctate distribution within the cytoplasm ([Fig. 5](#f0025){ref-type="fig"}E--H, J), whereas in neurons with lesser immunofluorescence localization to the cell surface was often not detected ([Fig. 5](#f0025){ref-type="fig"}K--L). In wild-type DRG specific immunofluorescence was not apparent ([Fig. 5](#f0025){ref-type="fig"}D). Previously we reported quantitative RT-PCR results showing that Gal~1~ mRNA decreased by 37% in wild-type mouse DRG seven days after sciatic nerve transection (axotomy; [@bb0200]), whereas here by cell counts of Gal~1~-mCherry immunoreactive neuronal profiles no apparent difference was detected between 10.9 ± 1.9% in control lumbar L4 and L5 DRG and 9.5 ± 1.1% in ipsilateral L4 and L5 DRG seven days after axotomy (each *n* = 3, ± SEM).

Within adult lumbar spinal cord, high levels of Gal~1~-mCherry immunofluorescence were detected in the superficial layers of the dorsal horn in lamina I--II processes, with lesser levels in the lateral spinal nucleus (LSN) and around the central canal in lamina X ([Fig. 6](#f0030){ref-type="fig"}A--C). Little immunofluorescence was detected in the ventral horn ([Fig. 6](#f0030){ref-type="fig"}D), and specific immunofluorescence was not detected in wild-type cord ([Supplementary Fig. 5](#f0065){ref-type="fig"}). Occasional intrinsic cell bodies were detected in lamina I/II, the lamina III/IV border and lamina X (boxed, [Fig. 6](#f0030){ref-type="fig"}E, G and H; [Supplementary Fig. 5](#f0065){ref-type="fig"}), the most highly expressing cells showing somatic cell membrane localization and puncta within the cell bodies ([Fig. 6](#f0030){ref-type="fig"}I--M). Outward transport of Gal~1~-mCherry from the cell body was detected as puncta within cell processes of multipolar neurons within the lamina III/IV border area ([Fig. 6](#f0030){ref-type="fig"}J, with further sections in [Supplementary Fig. 5](#f0065){ref-type="fig"}--J). In addition, we show a neuron within the medial part of lamina IV ([@bb0585]) extending a process laterally \~ 75 μm to end in a terminal containing multiple Gal~1~-mCherry immunofluorescent puncta, apposed to another Gal~1~-mCherry expressing neuron ([Fig. 6](#f0030){ref-type="fig"}N--P).

In wild-type brain no specific immunofluorescence was detected, whereas in similar sections of knock-in brain high levels of Gal~1~-mCherry immunoreactivity were detected within thalamus, hypothalamus and amygdala ([Fig. 7](#f0035){ref-type="fig"}A and B). Examples of the most immunoreactive brain regions are shown at higher magnification (5 ×), including the intermediate and ventral parts of the lateral septal nucleus ([Fig. 7](#f0035){ref-type="fig"}C and D); a number of thalamic nuclei including the paraventricular thalamic nucleus ([Fig. 7](#f0035){ref-type="fig"}E and F); the dorsomedial and ventromedial hypothalamic nuclei and median eminence ([Fig. 7](#f0035){ref-type="fig"}G); medial amygdala nuclei ([Fig. 7](#f0035){ref-type="fig"}H); and the locus coeruleus ([Fig. 7](#f0035){ref-type="fig"}I). Confocal images at higher magnification show localization of Gal~1~-mCherry to the somatic cell membrane of neurons within the lateral septal nucleus ([Fig. 7](#f0035){ref-type="fig"}J), high levels of expression in nerve endings within the external zone of the median eminence ([Fig. 7](#f0035){ref-type="fig"}K and L) and numerous nerve fibres in the locus coeruleus area ([Fig. 7](#f0035){ref-type="fig"}M).

Examples of brain regions with lesser Gal~1~-mCherry immunoreactivity (Materials and Methods) are shown in [Supplementary Fig. 6](#f0070){ref-type="fig"}. These include the mediocaudal part of the lateral posterior thalamic nucleus; pretectal nucleus; subiculum; medial mammillary nucleus; periaqueductal grey; posteromedial hippocampal amygdala; scattered cells in the ventral-most hippocampal pyramidal cell layer; the ventral part of the dorsal raphe nucleus and medial raphe nucleus. The correspondence of the higher magnification images ([Fig. 7](#f0035){ref-type="fig"} and [Supplementary Fig. 6](#f0070){ref-type="fig"}) to those at a lower magnification are shown in [Supplementary Fig. 7](#f0075){ref-type="fig"}, which also localize Gal~1~-mCherry immunoreactivity in the anterior hypothalamic area and anterior part of basomedial amygdala ([Supplementary Fig. 7](#f0075){ref-type="fig"}).

3.5. Absence of immunohistochemical detection of Gal~2~-hrGFP protein in adult knock-in mouse tissues {#s0095}
-----------------------------------------------------------------------------------------------------

A previously characterized antibody to hrGFP ([@bb0445; @bb0600]) specifically detected the protein expressed by CMV-driven hGal~2~-hrGFP cDNA in transiently transfected PC12 cells (data not shown). However, we could not detect specific Gal~2~-hrGFP protein expression by immunohistochemistry in adult normal DRG, spinal cord or brain, or in DRG and spinal cord after sciatic nerve axotomy which markedly induces Gal~2~ mRNA in rat ventral horn motoneurons ([@bb0055]). Immunofluorescence did not differ from wild-type tissue using a range of primary antibody dilutions (Materials and Methods), and omission of the primary antibody eliminated fluorescence. The inability to detect Gal~2~-hrGFP is compatible with the low endogenous expression of Gal~2~/Gal~2~-hrGFP mRNA ([Section 3.2](#s0080){ref-type="sec"}; see [Discussion](#s0100){ref-type="sec"} section).

4. Discussion {#s0100}
=============

The goal of this study was to produce knock-in mice expressing fluorescently-tagged Gal~1~ or Gal~2~ receptors for live-cell functional imaging and immunohistochemical localization studies. The Gal~1~-mCherry and Gal~2~-hrGFP mRNAs were each expressed and correctly spliced in adult DRG from the respective knock-in mice, but the steady-state levels of Gal~2~-hrGFP mRNA were decreased by \~ 50% compared to the endogenous Gal~2~ transcript of wild-type DRG. This may be due to the presence of mRNA stabilization sequence(s) present in the endogenous Gal~2~ mRNA 3′-UTR that do not occur in the heterologous 3′-UTR of Gal~2~-hrGFP mRNA ([Fig. 2](#f0010){ref-type="fig"}A), such as the stabilization motif CCTnCCTG-like sequence [A]{.ul}CTACCTG ([@bb0100]; NM_010254).

The live-cell imaging of Gal~1~-mCherry and Gal~2~-hrGFP proteins was restricted to the somatic cell membrane, axons and growth cones due to lipofuscin autofluorescence *within* the soma (see below). This still allowed the detection of Gal~1~-mCherry fluorescence localized to the somatic cell membrane, plus the demonstration of galanin-dependent internalization in DRG neurons. Previously, \[^125^I\]-galanin binding to neuronal cell bodies of intact monkey DRG or human nodose ganglion ([@bb0505; @bb0615]), lacked the spatial resolution to distinguish cell membrane from intracellular binding, whereas the increased membrane excitability upon addition of galanin to acutely dissociated rat DRG neurons indicated functional receptor(s) localized to the somatic cell membrane ([@bb0255]). Intact DRG neuron cell bodies have been shown to express surface receptors for a variety of neuroactive substances e.g. the GPCRs neuropeptide Y (NPY) type Y1 receptor (Y1-R) and somatostatin type 2A receptor (Sstr2A) ([@bb0180; @bb0475; @bb0610]).

Lipofuscin autofluorescence is known to complicate fluorescent microscopy of brain, spinal cord and DRG ([@bb0460]), for example identifying GFP-GR (glucocorticoid receptor) knock-in expression in brain ([@bb0525]), and will be exaggerated by the very sensitive detection conditions used here ([@bb0485]; [Materials and methods](#s0010){ref-type="sec"} section). Lipofuscin is composed of oxidized protein and lipid degradation residues, that is located within lysosomes but cannot be degraded by lysosomal hydrolases and so accumulates over time within post-mitotic cells such as neurons or cardiac myocytes ([@bb0500; @bb0510]). Studies on lipofuscin generally focus on aged animals, but it has been reported in 2 month old rat brain and heart ([@bb0235; @bb0375; @bb0500]), and in 6 week old brain and 1--3 month old spinal cord from mouse ([@bb0025; @bb0110; @bb0525]). The classical defining characteristic of lipofuscin is broad spectrum autofluorescence ([@bb0135; @bb0500]), as we detected in 500--700 nm emission spectral scans of wild-type DRG neurons (data not shown), which overlaps the commonly used fluorophores such as mCherry and hrGFP with emission peaks of respectively 610 and 506 nm ([@bb0465]; Stratagene-Agilent).

Gal~1~-mCherry protein was localized within DRG, spinal cord and brain using the higher sensitivity of immunohistochemistry ([Figs. 5-7](#f0025 f0030 f0035){ref-type="fig"}). Similarly, in the δ-opioid receptor (DOR)-EGFP knock-in mouse fluorescence was often weak and required EGFP-specific antibodies for proper visualization ([@bb0145]), and DOR and Gal~1~ mRNA are expressed at similar levels in mouse DRG based on next generation RNA sequencing (RNA-Seq; Supplementary Table 1 of [@bb0515]). Cellular localization of a specific GPCR can differ between different regions of the nervous system, for example DOR-EGFP is localized to the somatic cell membrane in DRG but is not readily detected at the cell surface of spinal cord neurons ([@bb0080; @bb0145; @bb0385]). In highly immunofluorescent Gal~1~-mCherry neurons, somatic cell membrane localization was detected in DRG ([Fig. 5](#f0025){ref-type="fig"}E--H, J), in spinal cord lamina I/II, lamina III/IV border, medial lamina IV and lamina X ([Fig. 6](#f0030){ref-type="fig"}I--K, M and O; [Supplementary Fig. 5](#f0065){ref-type="fig"}) and within brain in the lateral septal nucleus and locus coeruleus ([Fig. 7](#f0035){ref-type="fig"}J and M). In the live-cell imaging of primary DRG neurons we did not detect Gal~1~-mCherry fluorescence in growth cones or axons, which could be clearly viewed because lipofuscin autofluorescence is limited to the neuronal cell body ([@bb0170]). In contrast, the combination of the immunohistochemistry and the generally restricted expression among intrinsic spinal cord neurons allowed the detection of Gal~1~-mCherry transport within cell processes as puncta in successive confocal images of neurons within the lamina III/IV border area ([Fig. 6](#f0030){ref-type="fig"}J and [Supplementary Fig. 5](#f0065){ref-type="fig"}--J) and medial lamina IV ([Fig. 6](#f0030){ref-type="fig"}N--P; [@bb0585]).

Previously, we detected Gal~1~ mRNA in mouse DRG by RT-PCR ([@bb0200]), and here detected Gal~1~-mCherry immunofluorescence in a restricted subset of neurons ([Fig. 5](#f0025){ref-type="fig"}A--C, I) corresponding to 10.9% of lumbar L4 and L5 neuronal profiles. Published data on Gal~1~ mRNA + neuron profiles is not available for mouse DRG, but in adult rat DRG the initial figure was 23% whereas in a more sensitive study using labelled riboprobes the figure was 51% ([@bb0255; @bb0390; @bb0575]). Differences between mouse and rat DRG neuron profiles are not uncommon, for example between 7 and 20% for NPY receptor Y1 mRNA + or between 39 and 8% for P2X5 immunopositive profiles ([@bb0480; @bb0590]). In addition, immunohistochemical analysis can give lower numbers of positive neurons compared to ISH, as for example with DOR-EGFP immunostaining compared to DOR mRNA ISH in mouse DRG ([@bb0450; @bb0540]). The apparent lack of effect of axotomy on Gal~1~-mCherry immunoreactive neuronal profiles (9.5% versus control 10.9%), in combination with our previous quantitative RT-PCR results showing a 37% decrease in Gal~1~ mRNA in wild-type DRG ([@bb0200]), may be explained in part by a threshold for immunoreactive detection. If the mRNA decrease occurs mainly in the highly expressing neurons they would still maintain sufficient expression to be counted as Gal~1~-mCherry immunopositive. Consistent with this, an ISH study of NPY mRNA expression in rat superior cervical ganglion (SCG) after axotomy detected a 40% decrease in average grain density/neuron, but the number of NPY mRNA + neurons was unchanged ([@bb0285]).

In DRG the potential sources of galanin to bind to somatic cell membrane Gal~1~ are either via fenestrated capillaries that allow access into the neuronal extracellular space ([@bb0180]) or locally produced ligand. Basal expression of galanin mRNA and protein in DRG are low but increase dramatically after axotomy ([@bb0530; @bb0605]), when it is abundant in the Golgi region and also present stored in large dense-core vesicles within the cell body ([@bb0605]). Somatic exocytosis of galanin has yet to be studied, though it has been demonstrated for substance P (SP) and calcitonin gene-related peptide (CGRP) ([@bb0310; @bb0520]) and references therein), and in addition to post-axotomy would also be relevant following galanin induction in several other neuropathic pain models ([@bb0290]) and during nerve regeneration following nerve crush injury ([@bb0530]).

In mouse spinal cord expression of Gal~1~ mRNA has previously been detected by northern blot and RT-PCR ([@bb0245; @bb0545]), and by ISH was reported as enriched in the dorsal horn (Table 1 of [@bb0175]). We detected dense Gal~1~-mCherry immunofluorescence in the superficial dorsal horn laminae I--II with lesser levels in the lateral spinal nucleus and lamina X, similar to previous rat Gal~1~ mRNA ISH studies ([@bb0055; @bb0390]). It will be of interest to determine the expression of other neurochemical markers within intrinsic neurons highly expressing Gal~1~-mCherry. For example, the potential relationship of the multipolar neurons of the lamina III/IV border ([Fig. 6](#f0030){ref-type="fig"}G and J; [Supplementary Fig. 5](#f0065){ref-type="fig"}) to the occasional multipolar neurons of similar location that express galanin, NPY receptor Y1-R or somatostatin receptor Sstr2 ([@bb0050; @bb0345; @bb0475]), and the relationship of neurons lateral to the central canal and potentially interacting medial lamina IV neurons ([Fig. 6](#f0030){ref-type="fig"}M--P) to galanin or Y1R expressing cells ([@bb0050; @bb0090; @bb0345]).

The heterogeneous distribution of Gal~1~ mRNA in mouse forebrain has been determined by ISH ([@bb0210]) and was highly similar to \[^125^I\]-galanin binding sites, which were not detected in mice deficient for Gal~1~ ([@bb0250]). The examples of brain regions shown as the most Gal~1~-mCherry immunoreactive ([Fig. 7](#f0035){ref-type="fig"} and [Supplementary Fig. 7](#f0075){ref-type="fig"}) correspond, with three exceptions, to areas expressing Gal~1~ mRNA which on an intensity scale of + to ++++ (from weak to very dense) were in the range of ++ to ++++ ([@bb0210]). The ISH study did not extend caudally to the locus coeruleus and posterodorsal tegmental nucleus ([Fig. 7](#f0035){ref-type="fig"}I) which are known to bind \[^125^I\]-galanin ([@bb0250]), so the apparent discrepancy is in median eminence (ME) between the high level of Gal~1~-mCherry immunofluorescence ([Fig. 7](#f0035){ref-type="fig"}G, K and L) and the absence of Gal~1~ mRNA expression in both mouse and rat (Fig. 4d of [@bb0210; @bb0360]). However, Gal~1~ mRNA is detected in most hypothalamic nuclei that project towards it, and as there is a high density of \[^125^I\]-galanin binding sites in the ME of mouse and rat ([@bb0250]), these findings are therefore compatible with the hypothesis that median eminence Gal~1~ receptors are transported and play a local role at the nerve terminals ([@bb0360]). This is now clearly demonstrated by Gal~1~-mCherry immunofluorescence localized to densely packed nerve endings within the external zone of the ME ([Fig. 7](#f0035){ref-type="fig"}K--L), a blood--brain barrier-free circumventricular organ ([@bb0150; @bb0370]) with a very high density of galanin-immunoreactive fibres in both mouse and rat ([@bb0345; @bb0410]).

Brain regions with lesser Gal~1~-mCherry immunoreactivity ([Materials and methods](#s0010){ref-type="sec"} section; [Supplementary Fig. 6](#f0070){ref-type="fig"}) correspond to Gal~1~ mRNA intensities in the range + to ++ ([@bb0210]), or in the case of the lateral posterior thalamic nucleus is known to bind \[^125^I\]-galanin ([@bb0250]), while the dorsal raphe nucleus (DR) and median raphe nucleus were too caudal to be included in the ISH study. Gal~1~ mRNA is expressed in adult rat DR ([@bb0070; @bb0390]), but on the basis of a lack of Gal~1~-immunoreactivity or detection of Gal~1~ mRNA by ISH in mouse, a species difference in expression was proposed ([@bb0295]). Since then, \[^125^I\]-galanin binding sites and weak expression of Gal~1~ mRNA in the ventral part of mouse DR have been detected ([@bb0045; @bb0250]). Here we show Gal~1~-mCherry immunoreactivity in the DR ([Supplementary Fig. 6](#f0070){ref-type="fig"}), galanin receptor agonists having implicated mouse DR Gal~1~ in facilitating limbic seizures ([@bb0340]).

The difficulty in detecting Gal~2~-hrGFP fluorescence in the somatic cell membrane of DRG neurons can mainly be ascribed to comparatively low mRNA expression from the endogenous promoter. In wild-type mouse DRG the endogenous Gal~2~ mRNA was 148-fold less highly expressed than Gal~1~ ([Section 3.2](#s0080){ref-type="sec"}), which is consistent with data used in our previous report ([@bb0200]) in which Gal~2~ was 136-fold less highly expressed (difference of 7.09 cycles; each *n* = 5). This wide difference in expression of the two receptors is confirmed by RNA-Seq data of adult mouse DRG in which Gal~1~ and Gal~2~ had FPKM (Fragment Per Kilobase of exon per Million fragments mapped) values of 4.865 and 0.020, respectively (Supplementary Table 1 of [@bb0515]). The expression levels of Gal~2~-hrGFP in DRG, spinal cord and brain may be below the sensitivity for detection by immunohistochemistry, but Gal~2~ expression appears to be sufficient to affect behaviour. Gal~2~-deficient mice have anxiogenic-like and depression-like phenotypes ([@bb0015; @bb0325]), and compounds with a marked preference for binding Gal~2~ over Gal~1~ have anticonvulsive and anti-nociceptive activities ([@bb0350; @bb0435]).

Of direct relevance to the very low levels of Gal~2~-hrGFP, is the observation that Gal~2~ is likely to be under translational control mediated by upstream open reading frames (uORFs) within the 5′-UTR. This will tend to diminish translation of the main ORF by reducing the number of ribosomes reaching and initiating at the main start codon ([@bb0030; @bb0075]). Unlike the 5′-UTR of mouse and rat Gal~1~ mRNA sequences that do not contain upstream ATG triplets (NM_008082; NM_012958), those of mouse Gal~2~ contains six uORFs (here designated uORF1--6) whilst rat Gal~2~ contains only two uORFs ([Fig. 8](#f0040){ref-type="fig"}). These latter two are conserved between mouse and rat (hereafter uORF3 and uORF6) in both relative position and approximate length, potentially encoding 5 and 71/69 amino acids respectively, and the mouse/rat uORF6 terminates only 4 nucleotides upstream of the Gal~2~ initiation codon. Such proximity has previously been correlated with translational repression of the main coding sequence ([@bb0085; @bb0275]; but see [@bb0075]), as has uORF length ([@bb0075; @bb0280]), and uORF-mediated repression may or may not depend on the potential uORF-encoded protein sequence ([@bb0085; @bb0230; @bb0365]) but conservation of the uORF mRNA sequence between species suggests a functional selection ([@bb0095; @bb0125; @bb0230]).

Ribosome profiling (ribo-seq) data based on deep-sequencing of ribosome-protected mRNA fragments is not yet available for mouse neurons ([@bb0355]), but is for initiating ribosomes of the mouse ES cell line E14 in which Gal~2~ has low expression and ribosome density ([@bb0240]). The predicted initiation site of uORF6 has a ribosome footprint, with a peak density \~ 1.7-fold higher than at the Gal~2~ initiation site ([Materials and methods](#s0010){ref-type="sec"} section, [Section 2.1](#s0015){ref-type="sec"}; [@bb0240; @bb0355]), which suggests a functional role for the conserved uORF6. Intriguingly, endoplasmic reticulum (ER)-stress and a number of other stressors that transiently inhibit the translation of most mRNAs can also promote translation initiation of mRNAs with uORFs ([@bb0030; @bb0490]), and ER-stress is known to occur in vivo following neuronal axon damage, spinal cord injury or brain trauma ([@bb0305; @bb0380; @bb0580]). However, attempts to detect Gal~2~-hrGFP protein in DRG or spinal cord at 3 or 7 days after sciatic nerve peripheral axotomy were unsuccessful ([Section 3.5](#s0095){ref-type="sec"}). Further studies could be useful either in DRG after carrageenan-induced inflammation when Gal~2~ mRNA is induced in rat ([@bb0495]) or in the carotid body which has 100-fold more Gal~2~ than Gal~1~ mRNA in rat ([@bb0185; @bb0425]). There is now a clear need for in vitro studies on the mechanism of Gal~2~ translational control using various stressors ([@bb0030; @bb0490]) in order to understand both the conditions and time-courses of Gal~2~ protein expression, preferably in a neuronal-like cell line.

5. Conclusions {#s0105}
==============

The generation and initial characterization of the Gal~1~-mCherry knock-in mice will allow more detailed regional tissue distribution studies, co-localization studies, interactome analysis ([@bb0040]) and provide an impetus to understand the function of Gal~1~ at the somatic cell membrane. Expression of Gal~2~-hrGFP was at the limits of detection and a possible mechanism involving uORFs is discussed.

The following are the supplementary data related to this article.Supplementary Fig. 1Southern blot analysis of ES cell clones validates correct insertion of the *GalR1*-mCherry-\[*neo*^+^\] targeting construct. (A) Schematic diagram of the knock-in *GalR1*-mCherry-\[*neo*^+^\] allele showing the relative locations of: the targeting construct (grey horizontal thickened line); *GalR1* exon 3 coding sequence (CDS; black filled box); mCherry CDS (diagonal banded box); the heterologous 3′-UTR (grey filled box); downstream FRT sites (right arrowheads) flanking an SV40-*neo* cassette selection marker; the endogenous 3′-UTR (UTR); restriction sites AseI (A), BsrGI (Bs), BamHI (B) and an introduced AseI restriction site immediately downstream of the 3′ FRT site ([A]{.ul}); external 5′ and 3′ probes, *neo* probe, and hybridizing DNA fragments (see main article, [Fig. 1](#f0005){ref-type="fig"}A, for corresponding diagram of the endogenous allele). (B) DNA from six potential heterozygous *GalR1*-mCherry-\[*neo*^+^\] knock-in ES cell clones (33, 51, 63, 69, 93 and 97) and control wild-type mouse tail (wt) were digested and hybridized with: BsrGI and *GalR1* 5′ external probe (endogenous 7821 bp and knock-in 6158 bp; under-exposure for clone 93); AseI and *GalR1* 3′ external probe (endogenous 12,924 bp and knock-in 5386 bp); BamHI and *neo* probe (knock-in 3030 bp); or AseI and *neo* probe (knock-in 10,637 bp). The relative distance travelled by DNA ladder fragments (1 kb Plus, Life Technologies) are indicated in kb on the left of each panel. *Neo* was not detected in control wild-type mouse tail DNA, but an additional insertion of *neo*-hybridizing DNA was detected in ES cell clone 69 (arrowed) that was distinguishable from the correctly inserted knock-in fragment by digestion with BamHI or AseI. This additional *neo* insertion is due to only a fragment of introduced DNA ([Fig. 1](#f0005){ref-type="fig"}A, a grey horizontal thickened line), as the *neo*-hybridizing portion of AseI-digested DNA must be of at least 7366 bp which is larger than the additional hybridizing band of approximately 5500 bp, and quantitative genomic PCR detected only one copy of *GalR1*-mCherry.Supplementary Fig. 2Southern blot analysis of ES cell clones validates correct insertion of the *GalR2*-hrGFP-\[*neo*^+^\] targeting construct. (A) Schematic diagram of the knock-in *GalR2*-hrGFP-\[*neo*^+^\] allele showing the relative locations of: the targeting construct (grey horizontal thickened line); the 3′ end of the *GalR2* CDS (exon 2, black filled box) joined to knock-in elements as in Supplementary Fig. 1A except for exchanging hrGFP (diagonal banded box) for mCherry; the downstream terminal exon of *ExoC7* on the other DNA strand (unfilled box, arrowhead); restriction sites XmnI (X), BlpI (Bl, greytone) and BciVI (B); and external 5′ and 3′ probes, *neo* probe, and hybridizing DNA fragments (see main article, [Fig. 2](#f0010){ref-type="fig"}A, for corresponding diagram of the endogenous allele). \[BlpI sites are shown as used to characterize the \[Δ*neo*\] allele in main article [Fig. 2](#f0010){ref-type="fig"}.\] (B) DNA from six potential heterozygous *GalR2*-hrGFP-\[*neo*^+^\] knock-in ES cell clones (15, 30, 32, 33, 35 and 36) and control wild-type mouse tail (wt) were digested and hybridized with: BciVI and *GalR2* 5′ external probe (*left panel*; endogenous 5366 bp and knock-in 6026 bp); XmnI and *GalR2* 3′ external probe (*middle panel*; endogenous 6222 bp and knock-in 7930 bp); and BciVI and *neo* probe (*right panel*; knock-in 1653 bp). DNA ladder as [Fig. 1](#f0005){ref-type="fig"}B.Supplementary Fig. 3The knocked-in *GalR1*-mCherry gene is expressed and correctly spliced in adult DRG by RT-PCR analysis. Wild-type control (lanes 3 and 4), heterozygous *GalR1*-mCherry-\[*neo*^+^\] knock-in (lanes 5 and 6) and homozygous *GalR1*-mCherry-\[Δ*neo*\] knock-in mice (lanes 7 and 8) each expressed the correctly spliced product of *GalR1* exons 1--3 coding sequences (*top panel*, lanes 4, 6 and 8; 430 bp), whereas only knock-in mice express both the spliced product of *GalR1* exons 1--3 fused to mCherry (637 bp) and mCherry to the heterologous 3′-UTR (431 bp) (*middle panels*, lanes 6 and 8). Expression of *neo* was only detected in heterozygous *GalR1*-mCherry-\[*neo*^+^\] knock-in mice (*bottom panel*, lane 6; 630 bp). Knock-in mice were each of line 33. Lane 1 is a DNA ladder (1 kb Plus, Life Technologies) showing bands of 400, 500 and 650 bp; lane 2 is a water control; other even-numbered lanes are RT-PCRs using reverse transcribed RNA; and other odd-numbered lanes are corresponding reactions using RNA that has not been reverse transcribed (RT − controls), in which no products were detected.Supplementary Fig. 4The knocked-in *GalR2*-hrGFP gene is expressed and correctly spliced in adult DRG by RT-PCR analysis. Wild-type control (lanes 3 and 4), heterozygous *GalR2*-hrGFP-\[*neo*^+^\] knock-in (lanes 5 and 6) and homozygous *GalR2*-hrGFP-\[Δ*neo*\] knock-in mice (lanes 7 and 8) each expressed the correctly spliced product of *GalR2* exons 1-2 coding sequences (*top panel*, lanes 4, 6 and 8; 426 bp), whereas only knock-in mice express both GalR2 (exon 2) fused to hrGFP (533 bp) and hrGFP to the heterologous 3′-UTR (483 bp) (*middle panels*, lanes 6 and 8). Expression of *neo* was only detected in heterozygous *GalR2*-hrGFP-\[*neo*^+^\] knock-in mice (*bottom panel*, lane 6; 630 bp). Knock-in mice were each of line 32. Lane 1 is a DNA ladder showing bands of 400, 500 and 650 bp (1 kb Plus, Life Technologies); lane 2 is a water control; other even-numbered lanes are RT-PCRs using reverse transcribed RNA; and other odd-numbered lanes are corresponding reactions using RNA that has not been reverse transcribed (RT − controls), in which no products were detected.Supplementary Fig. 5Additional confocal images of Gal~1~-mCherry immunofluorescence in adult spinal cord. (A--F) Additional images of the multipolar neuron from the lamina III/IV border area shown in the main article ([Fig. 6](#f0030){ref-type="fig"}J). The multipolar morphology of the neuron is shown by a merged image of 20 *z*-sections (A; 40 × objective, zoom 6 ×), and single *z*-sections at different planes show multiple, discrete Gal~1~-mCherry immunofluorescent puncta located within the neuronal processes (arrows, B--F). (G--J) The morphology of another multipolar neuron from the lamina III/IV border area is shown by merged confocal sections at lower magnification (G, boxed; 40 × objective; 12 *z*-sections); and higher magnification (H; 40 × objective, zoom 6 ×; 15 *z*-sections), while single *z*-sections show multiple, discrete Gal~1~-mCherry immunofluorescent puncta located within the neuronal processes (arrows, I--J). (K--M) Additional examples of intrinsic neurons within lamina I--II are shown (K, boxed; 40 × objective), that at higher magnification show localization of Gal~1~-mCherry immunofluorescence to the somatic cell membrane (L--M; 40 × objective, zoom 6 ×; L, 5 *z*-sections). (N) Wild-type (wt) dorsal horn lacks specific immunofluorescence (20 × objective; scale bar 150 μm; FD, funiculus dorsalis) at the same brightness level as used for imaging Gal~1~-mCherry knock-in tissue in the main article ([Fig. 6](#f0030){ref-type="fig"}B--D and N). Each fluorescent image is a single optical section from a *z* stack, unless indicated. Scale bars are: 15 μm for 40 × objective, zoom 6 ×; 70 μm for 40 × objective; and 150 μm for 20 × objective images.Supplementary Fig. 6Photomicrograph images of Gal~1~-mCherry immunofluorescence in brain regions with lesser immunoreactivity. (A) In brighter images than main article [Fig. 7](#f0035){ref-type="fig"} (see below) there is still a lack of specific immunofluorescence in adult wild-type (wt) thalamus, in a section similar to knock-in brain with high Gal~1~-mCherry immunoreactivity ([Fig. 7](#f0035){ref-type="fig"}F). Gal~1~-mCherry immunofluorescence is now more easily detected in (B): the mediocaudal part of the lateral posterior thalamic nucleus (LPMC), pretectal nucleus (PtN; medial or posterior parts, MPT/PPT) and subiculum (S), but not in dentate gyrus (DG); (C): medial mammillary nucleus (MM) and periaqueductal grey (PAG); (D): posteromedial hippocampal amygdala (AHiPM) and scattered cells in the ventral hippocampal pyramidal cell layer (Py); (E): dorsomedial and ventrolateral periaqueductal grey (DMPAG, VLPAG) and ventral part of dorsal raphe nucleus (DRV); and (F): median raphe nucleus (MnR). Other abbreviations are: aq, aqueduct and 3V, 3rd ventricle. Image brightness in main article [Fig. 7](#f0035){ref-type="fig"} was constrained by the high immunoreactivity in thalamic nuclei, whereas here imaging used a 'gain' value of 2 rather than 1 with Image Manager IM50 software (Leica; Holmes et al., 2008). All images are micrographs using 5 × objective lens (scale bar 0.5 mm), (B)--(D) are from the same brain section (see Supplementary Fig. 7L) as are (E) and (F) (see Supplementary Fig. 7N and P). Sections are similar to mouse brain atlas Figures 46 (A), 54/55 (B--D) and 68 (E, F) of [@bb0160].Supplementary Fig. 7Comparison of high (5 ×) to low (2.5 ×) magnification photomicrograph images of Gal~1~-mCherry immunofluorescence in brain. Lefthand column is high power magnification images (5 ×) from main article [Fig. 7](#f0035){ref-type="fig"}C--F and I, and Supplementary Fig. 6B, E and F (designations shown in brackets, top right of each image). Righthand column is corresponding low power magnification images (designated '2.5 ×' in top left of each image). Additional brain areas specified here are the anterior hypothalamic area (AHP) and anterior part of basomedial amygdala (BMA) (Supplementary Fig. 7F). Note that 2.5 × magnification images of Supplementary Figs. 7H and L, respectively, also include the 5 × magnification images shown in [Fig. 7](#f0035){ref-type="fig"}G--H and Supplementary Fig. 6C--D. Scale bars are 0.5 mm (5 × objective) and 1 mm (2.5 × objective). Other abbreviations in alphabetical order are: aca, anterior part of anterior commissure; AHiPM, posteromedial hippocampal amygdala; aq, aqueduct; BMP, posterior part of basomedial amygdala nucleus; CB, cerebellum; CL, central lateral thalamic nucleus; CM, central medial thalamic nucleus; CPu, caudate putamen; DG, dentate gyrus; DM, dorsomedial ventromedial hypothalamic nucleus; DMPAG, dorsomedial part of periaqueductal grey; DRV, ventral part of dorsal raphe nucleus; IMD, intermediodorsal thalamic nucleus; LC, locus coeruleus; LPMC, lateral posterior thalamic nucleus; LSD, dorsal part of lateral septal nucleus; LSI, intermediate part of lateral septal nucleus; LSV, ventral part of lateral septal nucleus; MDM, medial part of mediodorsal thalamic nucleus; MHb, medial habenula; MM, medial mammillary nucleus; MnR, median raphe nucleus; MS, medial septal nucleus; PC, paracentral thalamic nucleus; PDTg, posterodorsal tegmental nucleus; PtN, pretectal nucleus; PV, paraventricular thalamic nucleus; S, subiculum; VLPAG, ventrolateral part of periaqueductal grey; VMH, ventromedial hypothalamic nucleus; 3V, 3rd ventricle; 4V, 4th ventricle.Supplementary material
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![Gene-targeting of *GalR1* and genotype analysis. (A) Schematic diagram of endogenous *GalR1* (*top panel*), knock-in *GalR1*-mCherry-\[*neo*^+^\] (*middle panel*) and knock-in *GalR1*-mCherry-\[Δ*neo*\] (*bottom panel*) alleles. Indicated relative locations are *GalR1* exon 3 with coding sequence (CDS; black filled box) and endogenous 3′-UTR ('UTR'; NM_008082, not full-length), and restriction sites AseI (A), BsrGI (Bs) and BamHI (B). The knock-in *GalR1*-mCherry-\[*neo*^+^\] DNA (*middle panel*) includes the following elements: the targeting construct (grey horizontal thickened line); the 3′ end of the *GalR1* CDS joined in-frame by a 21 nucleotide linker, encoding the flexible linker RDPPVAT ([@bb0165; @bb0315]), to mCherry CDS (diagonal banded box; mCherry protein sequence AAV52164); a heterologous 3′-UTR including the SV40 early region poly(A) site (grey filled box); downstream FRT sites (right arrowheads) flanking a SV40-*neo* cassette selection marker with a HSV (herpes simplex virus) thymidine kinase (*TK*) poly(A) site; an introduced AseI restriction site ([A]{.ul}) immediately downstream of the 3′ FRT site; and the endogenous 3′-UTR ('UTR') (see [Materials and methods](#s0010){ref-type="sec"} section). Locations of external 5′ and 3′ probes, *neo* probe, and hybridizing DNA fragments are also shown (see Supplementary Fig. 1A for more detailed image of \[*neo*^+^\] allele). Note that in the *GalR1*-mCherry-\[Δ*neo*\] knock-in allele (*bottom panel*) the SV40-*neo* cassette flanked by FRT sites has been removed by FLPe. (B) Southern blot analysis validates correct insertion of the targeting construct. Wild-type (W) and *GalR1*-mCherry-\[Δ*neo*\] knock-in line 33 (K) mouse tail DNA were digested and hybridized with: BsrGI and *GalR1* 5′ external probe (*left panel*; W: 7821 bp, K: 6158 bp); AseI and *GalR1* 3′ external probe (*middle panel*; W: 12,924 bp, K: 5386 bp); and BamHI and *neo* probe, which only hybridized to positive-control heterozygous *GalR1*-mCherry-\[*neo*^+^\] ES cell clone 33 (*right panel*; lane N: 3030 bp). The relative distance travelled by DNA ladder fragments (1 kb Plus, Life Technologies) is indicated in kb on the left of each panel.](gr1){#f0005}

![Gene-targeting of *GalR2* and genotype analysis. (A) Schematic diagram of endogenous *GalR2* (*top panel*), knock-in *GalR2*-hrGFP-\[*neo*^+^\] (*middle panel*) and knock-in *GalR2*-hrGFP-\[Δ*neo*\] (*bottom panel*) alleles. Indicated relative locations are the two exons of *GalR2* (boxed) with coding sequences (CDS; black filled boxes); the downstream terminal exon of *ExoC7* (exocyst complex component 7) on the other DNA strand (box with arrowhead); and restriction sites XmnI (X), BlpI (Bl, greytone) and BciVI (B). \[XmnI sites are shown as used to characterize the \[*neo*^+^\] allele (Supplementary Fig. 2).\] The knock-in *GalR2*-hrGFP-\[*neo*^+^\] DNA (*middle panel*) includes the targeting construct (grey horizontal thickened line), and the 3′ end of the *GalR2* CDS (exon 2) joined to knock-in elements as in [Fig. 1](#f0005){ref-type="fig"}A except for exchanging hrGFP (diagonal banded box; hrGFP protein sequence AAK63811) for mCherry. Locations of external 5′ and 3′ probes, *neo* probe, and hybridizing DNA fragments are also shown (see Supplementary Fig. 2A for more detailed image of \[*neo*^+^\] allele). Note that in the *GalR2*-hrGFP-\[Δ*neo*\] knock-in allele (*bottom panel*) the SV40-*neo* cassette flanked by FRT sites has been removed by FLPe. (B) Southern blot analysis of tail DNA from wild-type (W) and *GalR2*-hrGFP-\[Δ*neo*\] knock-in line 32 (K) mice validates correct insertion of the targeting constructs. DNA was digested and hybridized with: BciVI and *GalR2* 5′ external probe (*left panel*; W: 5366 bp, K: 6664 bp); BlpI and *GalR2* 3′ external probe (*middle panel*; W: 5466 bp, K: 6767 bp); and BciVI and *neo* probe, which only hybridized to positive-control heterozygous *GalR2*-hrGFP-\[*neo*^+^\] ES cell clone 32 (*right panel*; lane N: 1653 bp). DNA ladder as [Fig. 1](#f0005){ref-type="fig"}B.](gr2){#f0010}

![Detection of Gal~1~-mCherry and Gal~2~-hrGFP fluorescence by live-cell imaging. (A) Primary DRG neurons from *GalR1*-mCherry knock-in (cells 1--5) or wild-type (wt) mice are shown in brightfield images (*top row*); corresponding original fluorescent images, each acquired during the same imaging session with identical confocal settings (*middle row*); and corresponding adjusted images to emphasize somatic cell membrane fluorescence (see [Materials and methods](#s0010){ref-type="sec"} section), with cells 4, 5 and wt images treated identically (*bottom row*). Note that both knock-in and wild-type cells have *intracellular* autofluorescence within the neuronal cell body due to lipofuscin, but only knock-in cells have somatic *cell membrane* fluorescence. (B) Primary DRG neurons from *GalR2*-hrGFP knock-in (cells 1--3) or wild-type (wt1--3) mice are shown in brightfield images (*top row*); corresponding adjusted confocal fluorescent images (*second row*); corresponding brighter images to emphasize somatic cell membrane fluorescence (*third row*); and magnified fluorescent images from knock-in cells 1--3 at each of the two relative brightness levels (areas boxed in second and third rows), with arrows indicating the position of somatic cell membranes (*bottom row*). Knock-in and wild-type cells from the same imaging sessions are shown (1/wt1, 2/wt2 or 3/wt3). Note that expression of Gal~2~-hrGFP fluorescence at the somatic *cell membrane* is at the limits of detection, and that both knock-in and wild-type cells have *intracellular* autofluorescence within the cell body due to lipofuscin. For (A) and (B), each fluorescent image is a single optical section from a *z* stack, and the scale bar is 5 μm.](gr3){#f0015}

![Live-cell imaging of changes in Gal~1~-mCherry fluorescence at the somatic cell membrane following the addition of galanin. (A) Primary DRG neuron '1' from *GalR1*-mCherry knock-in mouse shown (left to right) in brightfield image; corresponding original confocal fluorescent images at time zero and at 20 min after addition of 1 μM galanin (+ gal), from which quantifications in (D) were made; and the same fluorescent images adjusted to emphasize cell membrane fluorescence (see [Materials and methods](#s0010){ref-type="sec"} section). (B) Corresponding images of primary DRG neuron '2'. (C) Magnified fluorescent images of each cell at both timepoints (areas boxed in (A) and (B)), with arrows indicating the position of somatic cell membranes. Each fluorescent image is a single optical section, and the scale bar ((A) and (B)) is 5 μm. (D) Quantification of changes in Gal~1~-mCherry fluorescence at the somatic cell membrane. Compared to somatic cell membrane fluorescence at time zero, defined as 100%, there was not a significant decrease in somatic cell membrane fluorescence in control neurons re-imaging 20 min later (*left*; 91.75 ± 3.76%, *n* = 4; *P* = 0.1155). In other cells imaged and then re-imaged 20 min after 1 μM galanin addition, there was a significant decrease in somatic cell membrane fluorescence to 65.17 ± 5.18% (*right*; *n* = 4; *P* = 0.0067; \*\*, *P* \< 0.01). The somatic cell membrane fluorescence at the 20 min timepoint also is significantly decreased in galanin-treated compared to control neurons (*n* = 4; *P* = 0.0089; \*\*, *P* \< 0.01).](gr4){#f0020}

![Detection of Gal~1~-mCherry immunofluorescence in DRG. (A--C) Three confocal images of adult *GalR1*-mCherry knock-in lumbar DRG show some neurons with comparatively high immunofluorescence (green colour, boxed) and others with lesser immunofluorescence whereas, (D) in adult wild-type (wt) DRG specific immunofluorescence is not detected (40 × objective, scale bar 40 μm). (E--H) Higher magnification images of highly immunofluorescent neurons (boxed in (A-C)) show localization of Gal~1~-mCherry to the somatic cell membrane and a punctate distribution within the cytoplasm (40 × objective, zoom 6 ×; scale bar 15 μm). (I) In a confocal image with high, moderate and low level immunofluorescent cells (boxed; scale bar 40 μm), at higher magnification somatic cell membrane localization is apparent in the high expressing neuron (J) but not in either a moderate (K, top) or two low expressing neurons (K bottom and L; scale bar 15 μm). Each fluorescent image is a single optical section from a *z* stack.](gr5){#f0025}

![Detection of Gal~1~-mCherry immunofluorescence in spinal cord. (A) Low-power photomicrograph (10 × objective) and (B--D) confocal images (20 × objective) of adult *GalR1*-mCherry knock-in lumbar spinal cord showing high levels of immunofluorescence in the superficial dorsal horn laminae I--II, with lesser levels in the lateral spinal nucleus (LSN, labelled '*L*') and around the central canal (white asterisk) in lamina X (A--C), whereas little immunofluorescence was detected in the ventral horn (D). (E--H) Higher magnified confocal images (40 × objective) of mid superficial dorsal horn (E); lateral superficial dorsal horn and LSN (labelled '*L*'; F); lamina III/IV border (G); and lamina X (H; central canal, white asterisk); with examples of local cell bodies boxed. (I--L, M) Higher magnification confocal images (40 × objective, zoom 6 ×) of local neurons (boxed in row above) show distinct somatic cell membrane localization in highly fluorescent cells of the superficial dorsal horn (I), lamina III/IV border (J) and lamina X (M; location arrowed in N, mainly different plane), whereas in less fluorescent neurons cell surface localization may (K, arrow; insert merged 3 *z*-sections) or may not be detected (K--L; L, merged 4 *z*-sections). Note the multiple Gal~1~-mCherry immunofluorescent puncta within neuronal processes (J, arrows; additional images in Supplementary Fig. 5A--F), and insert of M shows three main neuronal projections (each double arrows; merged 16 *z*-sections, 1 μm intervals). (N--P) Confocal images of medial spinal cord including a lamina IV neuron sending a process laterally to another Gal~1~-mCherry expressing neuron (boxed, N; 40 × objective); as shown at higher magnification to show the neuronal process (O; objective 40 ×, zoom 3 ×; merged 8 *z*-sections, 1 μm intervals), with insert images showing somatic cell membrane localization of each cell (right cell, merged 3 *z*-sections); and at further magnification Gal~1~-mCherry puncta are seen in the terminal process of the lamina IV neuron (arrows, P; objective 40 ×, zoom 8 ×; merged 7 *z*-sections, 1 μm intervals), with insert images of details from successive *z*-sections of the terminal process. *FD* is funiculus dorsalis. Each confocal image is a single optical section from a *z* stack unless indicated, with (B--D) at same brightness intensity, as are (E--H and N). Scale bars: 150 μm for 20 × objective; 70 μm for 40 × objective; 40 μm for 40 × objective with zoom 3 ×; and 15 μm for 40 × objective with either zoom 6 × or 8 ×.](gr6){#f0030}

![Detection of Gal~1~-mCherry immunofluorescence in brain. (A--B) In low-power micrographs (2.5 ×), specific immunofluorescence is not detected in adult wild-type (wt) brain (A), whereas in a similar section of adult *GalR1*-mCherry knock-in brain, high levels of Gal~1~-mCherry immunoreactivity were detected (B; see F-H for same section at higher magnifications). (C--I) Higher magnification images (5 ×) show high immunoreactivity in: (C) intermediate and ventral parts of lateral septal nuclei (LSI, LSV) and scattered cells within caudate putamen (CPu), but not in the dorsal part of the lateral septal nucleus (LSD) at this level or in medial septal nucleus (MS); (D) LSI, and scattered cells within CPu; (E--F) paraventricular-, medial mediodorsal-, central medial-, paracentral-, central lateral- and intermediodorsal-thalamic nuclei (PV; MDM; CM; PC; CL; IMD), but not in dentate gyrus (DG) or medial habenula (MHb); (G) dorsomedial and ventromedial hypothalamic nuclei (DM; VMH), median eminence (ME; see below) and scattered cells within posterior and lateral hypothalamic areas (PH; LH); (H) posterior basomedial and posterodorsal medial amygdala nuclei (BMP; MePD) and LH; (I) locus coeruleus (LC) and posterodorsal tegmental nucleus (PDTg), but not cerebellum (CB). (J--M) Confocal images at higher magnification (J--L: 40 ×; M: 40 ×, zoom 3 ×; scale bars 40 μm) showing: (J) somatic cell membrane localization in some neurons within the intermediate part of the lateral septal nucleus (LSI; arrows; area boxed in (D)); (K) high levels of expression in median eminence (ME) shown either over-bright to show location of third ventricle (3V; left pair of arrows showing join of torn tissue; 30 *z*-sections) or less-bright image (L; 3 *z*-sections), with insert of boxed area magnified to show immunoreactive fibres and an absence of immunoreactive cell bodies (40 ×, zoom 6 ×; scale bar 15 μm; 3 *z*-sections); and (M) fibres within the locus coeruleus (LC) area, together with a single cell body (arrow; 20 *z*-sections), with inserts showing somatic cell membrane localization (single *z*-sections). Other abbreviations: aca, anterior part of anterior commissure; and 4V, 4th ventricle. Images (A--B) and (C--I) are each at the same brightness intensity, with scale bars of 1 mm (A--B, 2.5 × objective) or 0.5 mm (C--I, 5 × objective lens). Sections are similar to mouse brain atlas Figures 46 (A, B), 23 (C), 29 (D, J), 40 (E), 46 (F--H, K, L) and 79 (I, M) of [@bb0160].](gr7){#f0035}

![Upstream open reading frames (uORFs) are present in mouse and rat Gal~2~ mRNA. Alignment of the 5′-UTR sequences of mouse and rat Gal~2~ mRNA showing uORFs, with ATG triplets (*bold underlined*, *red*) and associated ORFs (*bold*, *green*) upstream of the Gal~2~ coding region ('Gal~2~'; *bold*, *blue*) indicated, and note that of the six uORFs in the mouse sequence (uORF1-6) there is conservation of uORF3 and uORF6 in rat. For clarity, the open reading frame of mouse uORF4 is not indicated. Sequences shown are mouse (Mus) and rat mRNA reference sequences (respectively NM_010254 with 5′-UTR of 547 nt, and NM_019172 with 5′-UTR of only 20 nt), with additional rat 5′-UTR sequence derived from expressed sequence tag (EST) CB780446 and further extended by EST CB713787 to 466 nt. The rat sequence shares identity with the predicted rat Gal~2~ mRNA sequence (XM_008768432) and rat hypothalamic cDNA clones including 5′-UTRs of 492 and 296 bp have been reported, though the sequences are not available ([@bb0225]; U94322). The mouse sequence is supported by cDNAs/ESTs including uORF1-6 (AK053776, BC116980, BB607282), uORF2-6 (BC116982) and uORF5-6 (AK132050, BY712835) isolated from embryonic day 12 embryo or head, neonatal day 0 eyeball, and brain.](gr8){#f0040}

[^1]: Current address: MRC Harwell, Didcot, Oxfordshire OX11 0RD, UK.
